Short answer: Selank is one of the most misunderstood peptides sold in Canada. People buy it expecting a “natural Xanax,” confuse it with Semax, order a different molecule with a similar name, or read a handful of small Russian studies as if they were settled science. This guide walks through the nine mistakes we see most, what the research actually shows, and the one mistake that can be dangerous. Spoiler: it has nothing to do with the vial.
Selank has a reputation that has grown faster than its evidence. Search for it and you will find bold claims about calm without sedation, focus without stimulation, and anxiety relief without dependence. Some of that is grounded in real research. A lot of it is not. Knowing which is which will save you money and confusion.
First, what Selank actually is
Selank is a synthetic seven-amino-acid peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is built from tuftsin, a natural four-amino-acid fragment of an immunoglobulin, with a Pro-Gly-Pro tail added to make it more resistant to breakdown.
| Sequence | TKPRPGP (Thr-Lys-Pro-Arg-Pro-Gly-Pro) |
|---|---|
| Parent peptide | Tuftsin (TKPR) |
| Molecular weight | ≈ 751 Da |
| Research areas | Anxiety models, GABAergic signalling, BDNF, immune modulation |
| Regulatory status | Registered in Russia (nasal drops); not approved in Canada |
| Form supplied | Lyophilized powder |
Mistake #1: Calling it a “natural benzo”
This is the most common description online, and it is misleading in both directions.
Benzodiazepines like diazepam bind directly to a specific site on the GABA-A receptor and enhance its effect. That is why they work quickly, and also why they cause sedation, tolerance and dependence. Selank does not appear to work that way. Research suggests it acts indirectly: a 2016 study in Frontiers in Pharmacology found that Selank changed the expression of a number of genes involved in GABAergic neurotransmission in rat brain tissue, and other work points to effects on monoamines and BDNF.
So it is not a “benzo,” natural or otherwise. Different mechanism, much smaller evidence base, and no reason to assume it would match a benzodiazepine’s effect, good or bad.
Mistake #2: Confusing Selank with Semax
Same institute, similar-sounding names, both sold as nasal peptides in Russia. They are often bought together, and often confused. They are not interchangeable.
| Selank | Semax | |
|---|---|---|
| Built from | Tuftsin (immune peptide) | ACTH(4–10) fragment |
| Main research focus | Anxiety, calm, stress response | Cognition, neuroprotection, stroke recovery |
| Character studied | Anxiolytic | Nootropic, mildly stimulating |
We wrote a full breakdown here: Selank vs Semax: same lab, two very different peptides.
Mistake #3: Buying the wrong molecule
You will see “N-Acetyl Selank Amidate” (sometimes NA-Selank) sold right next to regular Selank, often at a premium and marketed as “stronger.” It is a modified version with an acetyl group on one end and an amide on the other, intended to make it more stable.
The problem: almost all of the published research, including the Russian clinical work, was done on regular Selank. The modified version has very little peer-reviewed data of its own. Paying more for it means paying for a marketing claim, not for evidence. If your research design is based on the published literature, you want the original molecule.
Mistake #4: Over-reading the Russian research
Most Selank research comes from Russian groups, published largely in Russian-language journals. That does not make it bad research. It does mean you should read it carefully, because the claims online are often stronger than the studies.
The most cited human study, by Zozulia and colleagues (2008), compared Selank with medazepam, a benzodiazepine, in patients with generalized anxiety disorder and neurasthenia. The authors reported similar anxiety reduction with fewer side effects. That is interesting. It was also a small study, published in a single national journal, and has not been replicated in a large Western randomized controlled trial.
Most of the remaining work is in animals:
- Gene expression: Volkova et al. (2016) reported changes in GABA-related gene expression in rat brain tissue after Selank.
- Interaction with diazepam: Kasian et al. (2017) found Selank enhanced diazepam’s anxiety-reducing effect in rats under chronic mild stress. Note what this implies: Selank can interact with benzodiazepines.
- BDNF: several rat studies report increased BDNF expression in the hippocampus after intranasal Selank.
How to read it: the evidence is enough to make Selank a reasonable research subject. It is not enough to support any claim of the form “Selank treats anxiety.”
Mistake #5: Assuming “approved in Russia” means approved here
Selank is registered in Russia as 0.15% nasal drops. Many sellers lean on that fact. It does not carry over.
- Selank is not approved by Health Canada, the US FDA or the European Medicines Agency.
- It is not a controlled substance in Canada.
- In Canada it is sold as a research chemical, for laboratory use only, not for human or veterinary use.
A Russian registration was based on Russian regulatory standards and data. It is not equivalent to a Health Canada review.
Mistake #6: Choosing the cheapest vial
Selank is short and relatively inexpensive to make, which sounds like good news. It also means it is easy to fake or substitute: a vial of almost any white powder looks identical. And because research on Selank measures subtle behavioural effects, a degraded or under-filled vial will not announce itself.
Insist on the same things you would for any peptide:
- Mass spectrometry identity, confirming the molecular weight of about 751 Da.
- HPLC purity, ideally 98% or higher.
- Lot-matched COA from a named lab.
- Domestic shipping, so it is not sitting in customs for weeks.
Our Selank COA is in the TrueLabs COA library.
Mistake #7: Storing it like a supplement
People who are used to capsules often leave peptide vials in a drawer. Peptides degrade with heat, light and moisture.
- Lyophilized: −20 °C long term, 2–8 °C short term, dark and dry.
- Reconstituted: refrigerated, protected from light, and used within the stability window your protocol specifies. Avoid freeze-thaw cycles.
- Diluent: bacteriostatic water for multi-use laboratory vials.
Full bench guide: how to reconstitute peptides.
Mistake #8: Expecting forum-level results
Forum reports of Selank range from “life-changing” to “felt nothing.” Both are anecdotes, with no control group, no blinding and every possible bias. Anxiety in particular responds strongly to placebo and to expectation, which is exactly why controlled trials exist. A dramatic forum story is not evidence, and neither is a disappointed one.
Mistake #9: The dangerous one
This is the one that matters most, and it has nothing to do with sourcing.
Never stop or reduce prescribed anxiety or mood medication because of something you read about Selank. Stopping benzodiazepines abruptly can cause serious withdrawal, including seizures. Stopping antidepressants suddenly can cause discontinuation symptoms and relapse. Any change has to be planned with the prescriber.
And remember the rat study above: Selank has been shown to interact with diazepam. Interactions with other medications have not been studied properly at all.
If you are researching Selank because you are struggling with anxiety yourself: please talk to a doctor. Effective, well-studied treatments exist, including therapy and approved medications, and you deserve care that is matched to you. If you are in crisis, call or text 9-8-8 in Canada.
The short version
| Mistake | The fix |
|---|---|
| “Natural benzo” | Different, indirect mechanism; much less data |
| Selank = Semax | Different parent peptides and research focus |
| Paying extra for NA-Selank | Most research used regular Selank |
| Over-reading the studies | Small, mostly animal, not replicated in large RCTs |
| “Approved in Russia” | Not approved in Canada; research use only |
| Cheapest vial | MS identity + lot-matched COA |
| Drawer storage | Cold, dark, dry |
| Forum expectations | Anecdotes are not evidence |
| Changing your medication | Never without your prescriber |
See TrueLabs Selank and its COA →
Frequently asked questions
Cliquez sur une question pour afficher la réponse.
What is Selank?
Selank is a synthetic seven-amino-acid peptide (TKPRPGP) based on tuftsin, developed in Russia and studied mainly in anxiety and stress models. It is registered in Russia as nasal drops and not approved in Canada.
Is Selank a benzodiazepine?
No. Benzodiazepines bind directly to the GABA-A receptor. Research suggests Selank acts indirectly, including by changing the expression of GABA-related genes, and its evidence base is far smaller.
What is the difference between Selank and N-Acetyl Selank Amidate?
N-Acetyl Selank Amidate is a chemically modified version designed for stability. Almost all published research, including the human studies, used regular Selank.
Is Selank legal in Canada?
Selank is not a controlled substance in Canada and is not approved by Health Canada. It is sold domestically as a research chemical for laboratory use only.
What is the difference between Selank and Semax?
Selank is derived from tuftsin and studied mainly for anxiety; Semax is derived from an ACTH fragment and studied mainly for cognition and neuroprotection.
Can Selank interact with medications?
Animal research found Selank enhanced the effect of diazepam, so interactions are possible. Interactions with other medications have not been properly studied.
Related reading
- Semax side effects
- Selank vs Semax: same lab, two very different peptides
- How to reconstitute peptides: laboratory guide
- How to choose a research peptide supplier in Canada
References
- Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38–48. PubMed
- Volkova A, Shadrina M, Kolomin T, et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. 2016;7:31. PubMed
- Kasian A, Kolomin T, Andreeva L, et al. Peptide Selank enhances the effect of diazepam in reducing anxiety in unpredictable chronic mild stress conditions in rats. Behav Neurol. 2017;2017:5091027. PMC
All TrueLabs products are sold for in vitro and laboratory research use only. They are not intended for human or veterinary use, and nothing in this article is medical advice. If you are dealing with anxiety, please talk to a doctor. In crisis in Canada, call or text 9-8-8.